Johnson & Johnson shares slide after $4.69B cancer case verdict

Yahoo Finance Video

Shares of Johnson & Johnson were sliding Friday morning, down 2.68%, the day after a St. Louis jury awarded $4.69 billion to the 22 women who said its talcum baby powder gave them ovarian cancer.

Scroll to continue with content

What to Read Next